SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients
NCT04402853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-12-03
Summary
Observational study to evaluate the presence of SARS COV-2 in tears collected in COVID-19 patients in Lombardia region, northern Italy, and to correlate virus presence to concomitant systemic clinical conditions.
Conditions
- Sars-CoV2
- Tear
Interventions
- DIAGNOSTIC_TEST
-
Tears swab
rtPCR on tears swabs samples
Sponsors & Collaborators
-
Università degli Studi dell'Insubria
lead OTHER
Principal Investigators
-
Simone Donati, Professor · University of Insubria, Varese
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2020-03-01
- Completion
- 2020-05-20
Countries
- Italy
Study Locations
More Related Trials
-
Assessment of COVID-19 in Tearfilm
NCT04579458 ·Status: WITHDRAWN
-
Dry Eye Under China's Dynamic COVID-zero Strategy
NCT05476068 ·Status: COMPLETED
-
Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
NCT04456556 ·Status: COMPLETED
-
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
NCT03230058 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis
NCT04451239 ·Status: UNKNOWN ·Phase: NA
-
Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia
NCT04951362 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
NCT04198740 ·Status: RECRUITING
-
The Effect of Antibiotic Eye Drops on the Nasal Microbiome in Healthy Subjects
NCT05287425 ·Status: COMPLETED ·Phase: PHASE2
-
PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye Symptoms
NCT05825352 ·Status: COMPLETED ·Phase: NA
-
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
NCT00426023 ·Status: COMPLETED ·Phase: PHASE3
-
Cytokine Profile of Conjunctivitis, Performed Through Tears Analysis Among Patients Treated With Dupilumab
NCT04066998 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
NCT00105469 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
NCT01481519 ·Status: COMPLETED ·Phase: PHASE3
-
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
NCT01028027 ·Status: COMPLETED ·Phase: PHASE3
-
Anosmia and / or Ageusia and Early Corticosteroid Use
NCT04528329 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis
NCT01120132 ·Status: COMPLETED ·Phase: PHASE2
-
Salivary Conductivity Screening for Dry Eye Disease and Sjögren's Syndrome
NCT06406933 ·Status: RECRUITING
-
Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation
NCT04633863 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis
NCT02804191 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Manuka Eye Drops on Tear Film Properties
NCT03622619 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics
NCT00831961 ·Status: COMPLETED
-
Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs
NCT02819232 ·Status: COMPLETED ·Phase: NA
-
Characterization of Subjective Discomfort in Patients With Tear Dysfunction
NCT06819631 ·Status: NOT_YET_RECRUITING
-
Clinical Feature and Treatment of Microsporidial Keratoconjunctivitis
NCT03555409 ·Status: UNKNOWN